Chromogenic in Situ Hybridization : A Practical Alternative for Fluorescence in Situ Hybridization to Detect HER-2/neu Oncogene Amplification in Archival Breast Cancer Samples

Determination of HER-2/neu oncogene amplification has become necessary for selection of breast cancer patients for trastuzumab (Herceptin) therapy. Fluorescence in situ hybridization (FISH) is currently regarded as a gold standard method for detecting HER-2/neu amplification, but it is not very prac...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tanner, Minna, Gancberg, David, Di Leo, Angelo, Larsimont, Denis, Rouas, Ghizlane, Piccart, Martine J., Isola, Jorma
Format: Artigo
Langue:Inglês
Publié: American Society for Investigative Pathology 2000
Sujets:
Technical Advances
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1885742/
https://ncbi.nlm.nih.gov/pubmed/11073807
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires